ClinicalTrials.gov record
Completed Phase 2 Interventional

GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting

ClinicalTrials.gov ID: NCT00125398

Public ClinicalTrials.gov record NCT00125398. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 4:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Open-Label Study to Examine the Safety and Efficacy of GPI 15715 for Sedation of Patients Requiring Intubation and Mechanical Ventilation in the Intensive Care Unit Setting

Study identification

NCT ID
NCT00125398
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • AQUAVAN (fospropofol disodium; GPI 15715 ) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2005
Primary completion
Not listed
Completion
Apr 30, 2007
Last update posted
Nov 6, 2008

2005 – 2007

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
St. Mary's Hospital Rogers Arizona 72756
Jackson Memorial Hospital Miami Florida 33136
Advocate Lutheran General Hospital Park Ridge Illinois 60068
University of Iowa Hospital and Clinics Iowa City Iowa 52242
Central Maine Pulmonary Associates Auburn Maine 04210
Boston Medical Center Boston Massachusetts 02118
Henry Ford Hospital Detroit Michigan 48202
Cooper University Hospital Camden New Jersey 08103
Long Island Jewish Medical Center New Hyde Park New York 11040
New York University School of Medicine New York New York 10016
Mount Sinai School of Medicine New York New York 10029
Montefiore Medical Center The Bronx New York 10467
Duke University Medical Center Durham North Carolina 27710
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157
Oklahoma University Medical Center Oklahoma City Oklahoma 73104
Vanderbilt University Medical Center Nashville Tennessee 37232
Department of Veterans Affairs, North Texas Health Care System Dallas Texas 75216

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00125398, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2008 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00125398 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →